These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22007759)

  • 1. Elephantiasic pretibial myxoedema with upper-limb involvement, treated with low-dose intravenous immunoglobulins.
    Dhaille F; Dadban A; Meziane L; Fessier C; Colta L; Lok C; Chaby G
    Clin Exp Dermatol; 2012 Apr; 37(3):307-8. PubMed ID: 22007759
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of response of elephantiasic pretibial myxoedema to treatment with high-dose intravenous immunoglobulins.
    Terheyden P; Kahaly GJ; Zillikens D; Bröcker EB
    Clin Exp Dermatol; 2003 Mar; 28(2):224-6. PubMed ID: 12653721
    [No Abstract]   [Full Text] [Related]  

  • 3. Dramatic effect of low-dose oral steroid on elephantiasic pretibial myxedema.
    Shirai K; Ito T; Mitsuhashi Y; Tsuboi R
    J Dermatol; 2014 Oct; 41(10):941-2. PubMed ID: 25200964
    [No Abstract]   [Full Text] [Related]  

  • 4. [Elephantiasic pretibial myxoedema: study of five cases].
    Niang SO; Diallo M; Kane A; Bocoum TI; Dieng MT; Ndiaye B
    Dakar Med; 2007; 52(2):95-9. PubMed ID: 19102101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of high-dose intravenous immunoglobulin treatment of patients with pretibial myxedema and Basedow's disease. Preliminary findings].
    Antonelli A; Saracino A; Agostini S; Alberti B; Melosi A; Gambuzza C; Avantaggiato G; Baschieri L
    Clin Ter; 1992 Sep; 141(9 Pt 2):63-8. PubMed ID: 1281765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose intravenous immunoglobulin infusion as treatment for diffuse scleroderma.
    Ihn H; Mimura Y; Yazawa N; Jinnin M; Asano Y; Yamane K; Tamaki K
    Br J Dermatol; 2007 May; 156(5):1058-60. PubMed ID: 17381465
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment-resistant elephantiasic thyroid dermopathy responding to rituximab and plasmapheresis.
    Heyes C; Nolan R; Leahy M; Gebauer K
    Australas J Dermatol; 2012 Feb; 53(1):e1-4. PubMed ID: 22309343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Elephantiasic Pretibial Myxedema With Rituximab Therapy.
    Patel S; Choi D; Christianakis S; Wysong A; Crew A
    Cutis; 2022 Feb; 109(2):E16-E18. PubMed ID: 35659798
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome.
    Kito Y; Ito T; Tokura Y; Hashizume H
    Acta Derm Venereol; 2012 Jan; 92(1):100-1. PubMed ID: 21681351
    [No Abstract]   [Full Text] [Related]  

  • 10. High dose intravenous immunoglobulin treatment: mechanisms of action.
    Boros P; Gondolesi G; Bromberg JS
    Liver Transpl; 2005 Dec; 11(12):1469-80. PubMed ID: 16315304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin therapy: methods of delivery.
    Ballow M
    J Allergy Clin Immunol; 2008 Nov; 122(5):1038-9. PubMed ID: 18804269
    [No Abstract]   [Full Text] [Related]  

  • 12. Elephantiasic thyroid dermopathy.
    Tiu SC; Choi CH
    Hong Kong Med J; 2006 Apr; 12(2):159-60. PubMed ID: 16603786
    [No Abstract]   [Full Text] [Related]  

  • 13. An evaluation of the impact of a single-dose intravenous immunoglobulin regimen in the treatment of Clostridium difficile infections.
    Aldeyab MA; McElnay JC; Scott MG; Davies E; Edwards C; Darwish Elhajji FW; Conlon G; Magee FA; Barr PJ; Kearney MP
    Infect Control Hosp Epidemiol; 2011 Jun; 32(6):631-3. PubMed ID: 21558782
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab and intravenous immunoglobulins for relapsing postinfectious opsoclonus-myoclonus syndrome.
    Leen WG; Weemaes CM; Verbeek MM; Willemsen MA; Rotteveel JJ
    Pediatr Neurol; 2008 Sep; 39(3):213-7. PubMed ID: 18725071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Experience with Rituximab and Intravenous Immunoglobulin for Pretibial Myxedema: A Case Series.
    Kotwal A; Turcu AF; Sonawane V; Bahn RS; Pittelkow MR; Bridges A; Stan MN
    Thyroid; 2019 May; 29(5):692-699. PubMed ID: 30854936
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV-associated nemaline rod myopathy: role of intravenous immunoglobulin therapy in two persons with HIV/AIDS.
    de Sanctis JT; Cumbo-Nacheli G; Dobbie D; Baumgartner D
    AIDS Read; 2008 Feb; 18(2):90-4. PubMed ID: 18330038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Images in vascular medicine. A singular case of elephantiasic nodular pretibial myxedema.
    Dean SM; Bechtel MA
    Vasc Med; 2008 Feb; 13(1):85-6. PubMed ID: 18372444
    [No Abstract]   [Full Text] [Related]  

  • 19. New choices for treatment with subcutaneous immunoglobulins.
    Pleguezuelo DE; Sánchez-Ramón S
    Med Clin (Barc); 2017 Jan; 148(2):86-90. PubMed ID: 27919413
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful therapy of scleromyxoedema Arndt-Gottron with low-dose intravenous immunoglobulin.
    Körber A; Franckson T; Grabbe S; Dissemond J
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):553-4. PubMed ID: 17373996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.